Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Anchorage. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Anchorage location
Access non-small cell lung cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-small cell lung cancer treatment provided free
Check if you qualify for this non-small cell lung cancer clinical trial in Anchorage, AK
No-Cost Study Care
Local to Anchorage
Convenient for AK residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II Lung-MAP treatment trial test the combination of targeted drugs (capmatinib, osimertinib, and/or ramucirumab) in treating patients with non-small cell lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and that has EGFR and MET gene changes. Capmatinib and osimertinib are in a class of medications called kinase inhibitors. They work by blocking the action of the abnormal protein that signals cancer cel
Sponsor: SWOG Cancer Research Network
Yes, this clinical trial (NCT05642572) has an active research site in Anchorage, AK that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for non-small cell lung cancer treatment options in Anchorage, AK, this clinical trial (NCT05642572) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anchorage research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all non-small cell lung cancer clinical trials near you to find additional studies recruiting in your area.
See all lung cancer clinical trials recruiting in Anchorage — not just this study.
Browse Lung Cancer Trials in Anchorage →